Abstract
SummaryTreatment by heterologous DNA administered after whole-body irradiation improved survival and accelerated the recovery of body-weight and of the counts of red blood cells, granulocytes and lymphocytes in the peripheral blood. There was no secondary disease or change in the blood count during the next 12 months.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
